|Articles|May 5, 2003
Alcon reports findings of two moxifloxacin studies
Alcon Laboratories announced the results of two clinical studies on itsfourth-generation fluoroquinolone moxifloxacin (Vigamox). The results werepresented in a Monday morning poster session.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
PRIMAvera study: Central vision improvement with subretinal implant
2
FDA approvals in 2025: What changed and why it matters for ophthalmologists
3
Refractory dry eye care: How systemic conditions change the game
4
The year in optometry: 10 stories that defined eye care in 2025
5